Clinical Trials

500 enrolled

Esophageal Neoplasms

NCT04503694 2026-03-27

REGINA

72 enrolled

Rectal Neoplasms

NCT05826509 2026-03-27

SUGAR

240 enrolled

Prostatic Neoplasms

NCT01428895 2026-03-06

Femoral Bone Metastases

180 enrolled

Tumor-Agnostic

Neoplasms

NCT02125786 2026-02-24

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

68 enrolled 11 charts

Ependymoma

NCT01946529 2026-02-23

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Phase 1 Active not recruiting

24 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT04606316 2026-02-17

Surgical Nivolumab And Ipilimumab For Recurrent GBM

63 enrolled

Glioblastoma

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Advanced Biliary Tract Carcinoma

NCT02926911 2026-01-27

COMET

997 enrolled 16 charts

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal

NCT06660810 2026-01-15

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

2 enrolled

Sarcoma

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT05735912 2026-01-13

ERASIN-RCT

60 enrolled

Endocrine

Insulinoma

NCT05278741 2025-12-26

BREAST

32 enrolled

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

115 enrolled

Sarcoma

Rhabdomyosarcoma

NCT01723774 2025-12-09

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

84 enrolled 17 charts

Breast Neoplasms

NCT07272356 2025-12-09

Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function

68 enrolled

Carcinoma, Non-Small-Cell Lung, Respiratory Aspiration

NCT05882513 2025-12-02

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06132087 2025-11-25

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

2 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT02792582 2025-11-12

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

160 enrolled

Brain Neoplasms, Craniopharyngioma

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

20 enrolled 11 charts

Urinary Bladder Neoplasms

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

168 enrolled

Pancreatic Neoplasms

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

60 enrolled

Colonic Neoplasms

NCT02981940 2025-09-02

A Study of Abemaciclib in Recurrent Glioblastoma

45 enrolled 10 charts

Brain Neoplasms, Glioblastoma

NCT06027541 2025-08-03

Young Patients With Early Breast Cancer

1,000 enrolled

Phase 2/3 Active not recruiting

Breast Cancer Female

NCT07076693 2025-07-22

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

97 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04062708 2025-07-08

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04404777 2025-06-17

LERIS

12,000 enrolled

Rectal Neoplasms

NCT01792934 2025-04-15

ORCHESTRA

478 enrolled

Multi-organ Metastatic Colorectal Cancer

NCT00938145 2025-04-11

3 Tesla MRI in Patients With Bladder Cancer

98 enrolled

Urinary Bladder Neoplasms

NCT04198181 2025-01-17

The Effectiveness and Safety of Resective Epilepsy Surgery for TRE

200 enrolled

Epilepsy, Tuberous Sclerosis

NCT06762158 2025-01-07

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

50 enrolled

Esophageal Squamous Cell Carcinoma

NCT03343236 2024-12-13

Nutrition and Inflammation in Patients With Head and Neck Cancer

522 enrolled

Head & Neck

Head and Neck Neoplasms, Inflammation, Radiation Injuries

NCT01553942 2024-11-20

Afatinib With CT and RT for EGFR-Mutant NSCLC

19 enrolled

Lung Neoplasms

NCT05724329 2024-09-19

Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)

24 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02641093 2024-08-29

Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

Phase 3 Active not recruiting

96 enrolled 12 charts

Head & Neck

Head and Neck Neoplasms

NCT03879109 2024-08-14

GRECCAR15

58 enrolled

Rectal Neoplasms

NCT04945928 2024-05-24

Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC

Lung Neoplasms

NCT03982485 2024-04-30

APP

196 enrolled

Breast Neoplasms

NCT04997941 2024-04-23

MORE-T

238 enrolled

Premenopausal Breast Cancer

NCT03189420 2024-04-19

Glioma Microenvironment an Exploratory Study

Phase 3 Active not recruiting

Glioblastoma, Glioma

NCT03595592 2024-03-06

APTneo

650 enrolled

Invasive Breast Cancer

NCT06277518 2024-02-26

System for Postoperative Admission to ICU for Patients With Digestive System Malignancy

2,000 enrolled

Intensive Care Unit Syndrome

NCT01717131 2024-01-11

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

2,228 enrolled

Invasive Breast Cancer

NCT03840239 2023-10-25

TESS

98 enrolled

Rectal Neoplasms

NCT05602935 2023-09-28

Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study

29 enrolled

Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Site, Stomach Diseases, Stomach Neoplasms

NCT04028986 2023-05-16

Esmya Versus Surgery Before IVF/ICSI

Phase 1/2 Active not recruiting

40 enrolled

Gynecologic

Infertility, Female, Leiomyoma, Pregnancy Complications, Uterine Neoplasms

NCT03544736 2023-03-22

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

Phase 3 Active not recruiting

Esophageal Neoplasms

NCT00430183 2023-02-09

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

788 enrolled 10 charts